Literature DB >> 18583913

Investigation of +405 and -460 polymorphisms of vascular endothelial growth factor in psoriasis and short-term responsiveness to efalizumab therapy.

I Stefanaki, G Dimisianos, C Antoniou, A Katsambas, A Stratigos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18583913     DOI： 10.1159/000141651

Source DB:  PubMed          Journal:  Dermatology        ISSN： 1018-8665            Impact factor:   5.366


× No keyword cloud information.
  1 in total

1.  Genetic Risk Factors for Psoriasis in Turkish Population: -1540 C/A, -1512 Ins18, and +405 C/G Polymorphisms within the Vascular Endothelial Growth Factor Gene.

Authors:  Tuba Bozduman; Sibel Ersoy Evans; Sevilay Karahan; Yildiz Hayran; Filiz Akbiyik; Incilay Lay
Journal:  Ann Dermatol       Date:  2016-01-28       Impact factor: 1.444
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.